4//SEC Filing
Neervannan Seshadri 4
Accession 0001819790-25-000058
CIK 0001819790other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 9:49 PM ET
Size
7.8 KB
Accession
0001819790-25-000058
Insider Transaction Report
Form 4
Neervannan Seshadri
Chief Operating Officer
Transactions
- Sale
Common Stock
2025-03-19$47.40/sh−2,543$120,538→ 82,117 total - Sale
Common Stock
2025-03-18$46.29/sh−2,605$120,585→ 84,660 total - Sale
Common Stock
2025-03-20$50.11/sh−2,435$122,018→ 79,682 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001827584
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 9:49 PM ET
- Size
- 7.8 KB